amoxicillin + clavulanic acid




Concise Prescribing Info
Co-amoxiclav (Amoxicillin & clavulanic acid). Per 625 mg FC tab Clavulanate K 125 mg, amoxicillin 500 mg. Per 1 g FC tab Clavulanate K 125 mg, amoxicillin 875 mg. Per 228.5 mg/5 mL BID susp Clavulanate K 28.5 mg, amoxicillin 200 mg. Per 457 mg/5 mL BID susp Clavulanate K 57 mg, amoxicillin 400 mg
675-mg FC tab: Lower resp tract infections (eg, pneumonia, bronchitis), acute otitis media, sinusitis, UTI, skin & soft tissue infections. 1-g FC tab: Upper including otorhinolaryngeal (eg, sinusitis, otitis media, tonsilitis) & lower (eg, lobar & bronchopneumonia, acute & chronic bronchitis) resp tract infections, GUT infections (eg, cystitis, urethritis, pyelonephritis), skin & soft tissue infections (eg, boils, abscesses, cellulitis, wound infections), bone & joint infections (eg, osteomyelitis), dental infections (eg, dentoalveolar abscess), septic abortion, puerperal sepsis, intra-abdominal sepsis. Susp: Short-term treatment of bacterial infections at the following sites when amoxicillin resistant β-lactamase producing strains are suspected as a cause: Upper (including ENT; particularly sinusitis, otitis media, recurrent tonsillitis) & lower (particularly acute exacerbations of chronic bronchitis, lobar & bronchopneumonia) resp tract infections, UTI (particularly cystitis).  
Dosage/Direction for Use
FC tab Mild to moderate infections Adult & childn ≥12 yr 625 mg bid. 625-mg FC tab Severe infections & resp tract infections 625 mg every 8 hr. 1-g FC tab Severe infections 1 g bid. Dental infections (eg, dentoalveolar abscess) Adult & childn >12 yr 1 g bid for 5 days. Severe renal impairment (CrCl <10 mL/min) Not more than 625 mg every 24 hr. Moderate renal impairment 625 mg bid. Susp Adult & childn (wt >40 kg) 250-500 mg every 8 hr or 500-875 mg every 12 hr. Max: 2-3 g/day. Childn (wt <40 kg) 20-50 mg/kg/day divided every 8-12 hr or 125-250 mg every 8 hr or 200-400 mg every 12 hr. Dose interval: Renal impairment CrCl >15-30 mL/min Every 8 hr, 10-30 mL/min Every 12 hr, <10 mL/min Every 24 hr.
May be taken with or without food: Take at the start of meals for better absorption & to reduce GI discomfort. 1-g tab: Swallow whole, do not chew. Tab may be broken in half & swallowed w/o chewing.
Penicillin hypersensitivity. Possible cross-sensitivity w/ β-lactam antibiotics. History of penicillin-associated jaundice/hepatic dysfunction.
Special Precautions
History of penicillin hypersensitivity & or multiple allergens sensitivity. Pseudomembranous colitis. FC tab: Childn <12 yr. 1-g tab: Severe hepatic dysfunction. Do not use in patients w/ moderate to severe renal impairment (CrCl <30 mL/min). Patients receiving anticoagulants. Susp: Phenylketonurics. 1-g FC tab & susp: Superinfections w/ mycotic or bacterial pathogens may occur during therapy. Avoid in pregnancy especially 1st trimester. False positive results w/ copper-reduction test & Coombs' test.
Adverse Reactions
Diarrhoea, indigestion, nausea, vomiting, mucocutaneous candidiasis, discomfort, anorexia, flatulence, dyspepsia, gastritis, stomatitis, glossitis, black or hairy tongue & enterocolitis; antibiotic associated pseudomembranous colitis; erythematous rash & urticaria; angioedema, serum sickness; anemia, thrombocytopenia, leukopenia, agranulocytosis.
Drug Interactions
Decreased renal tubular secretion w/ probenecid. Increased incidence of rash w/ allopurinol. 1-g FC tab & susp: Anticoagulants. May reduce efficacy of OCs.
MIMS Class
ATC Classification
J01CR02 - amoxicillin and beta-lactamase inhibitor ; Belongs to the class of penicillin combinations, including beta-lactamase inhibitors. Used in the systemic treatment of infections.
Ranclav 1 g FC tab
10 × 2's
Ranclav 625 mg FC tab
10 × 10's
Ranclav 228.5 mg/5 mL BID oral susp
70 mL x 1's
Ranclav 457 mg/5 mL BID oral susp
50 mL x 1's;70 mL x 1's
/thailand/image/info/ranclav 457 mg-5 ml bid oral susp/457 mg-5 ml (70 ml)?id=9324782e-de56-4ddf-b396-ace100f76e85
/thailand/image/info/ranclav 457 mg-5 ml bid oral susp/457 mg-5 ml (50 ml)?id=d51a3591-f117-48cb-a99a-ace100f76e85
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in